Bernard J Hanseeuw1,2, Matthew R Scott3, Sietske A M Sikkes3,4, Michael Properzi3, Jennifer R Gatchel5,6, Eric Salmon7, Gad A Marshall3,8, Patrizia Vannini3,8. 1. Department of Neurology, Cliniques Universitaires Saint-Luc, and Institute of Neuroscience, Catholic University of Louvain, Brussels, Belgium. 2. Department of Neurology and Radiology, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 3. Department of Neurology and Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 4. Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center, VU University, Amsterdam, the Netherlands. 5. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 6. Division of Geriatric Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA. 7. GIGA Cyclotron Research Center-IVI, University of Liege, Quartier Agora, Sart Tilman, Belgium. 8. Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Abstract
OBJECTIVE: Unawareness, or anosognosia, of memory deficits is a challenging manifestation of Alzheimer's disease (AD) that adversely affects a patient's safety and decision-making. However, there is a lack of consensus regarding the presence, as well as the evolution, of altered awareness of memory function across the preclinical and prodromal stages of AD. Here, we aimed to characterize change in awareness of memory abilities and its relationship to beta-amyloid (Aβ) burden in a large cohort (N = 1,070) of individuals across the disease spectrum. METHODS: Memory awareness was longitudinally assessed (average number of visits = 4.3) and operationalized using the discrepancy between mean participant and partner report on the Everyday Cognition scale (memory domain). Aβ deposition was measured at baseline using [18F]florbetapir positron emission tomographic imaging. RESULTS: Aβ predicted longitudinal changes in memory awareness, such that awareness decreased faster in participants with increased Aβ burden. Aβ and clinical group interacted to predict change in memory awareness, demonstrating the strongest effect in dementia participants, but could also be found in the cognitively normal (CN) participants. In a subset of CN participants who progressed to mild cognitive impairment (MCI), heightened memory awareness was observed up to 1.6 years before MCI diagnosis, with memory awareness declining until the time of progression to MCI (-0.08 discrepant-points/yr). In a subset of MCI participants who progressed to dementia, awareness was low initially and continued to decline (-0.23 discrepant-points/yr), reaching anosognosia 3.2 years before dementia onset. INTERPRETATION: Aβ burden is associated with a progressive decrease in self-awareness of memory deficits, reaching anosognosia approximately 3 years before dementia diagnosis. ANN NEUROL 2020;87:267-280.
OBJECTIVE: Unawareness, or anosognosia, of memory deficits is a challenging manifestation of Alzheimer's disease (AD) that adversely affects a patient's safety and decision-making. However, there is a lack of consensus regarding the presence, as well as the evolution, of altered awareness of memory function across the preclinical and prodromal stages of AD. Here, we aimed to characterize change in awareness of memory abilities and its relationship to beta-amyloid (Aβ) burden in a large cohort (N = 1,070) of individuals across the disease spectrum. METHODS: Memory awareness was longitudinally assessed (average number of visits = 4.3) and operationalized using the discrepancy between mean participant and partner report on the Everyday Cognition scale (memory domain). Aβ deposition was measured at baseline using [18F]florbetapir positron emission tomographic imaging. RESULTS: Aβ predicted longitudinal changes in memory awareness, such that awareness decreased faster in participants with increased Aβ burden. Aβ and clinical group interacted to predict change in memory awareness, demonstrating the strongest effect in dementiaparticipants, but could also be found in the cognitively normal (CN) participants. In a subset of CN participants who progressed to mild cognitive impairment (MCI), heightened memory awareness was observed up to 1.6 years before MCI diagnosis, with memory awareness declining until the time of progression to MCI (-0.08 discrepant-points/yr). In a subset of MCIparticipants who progressed to dementia, awareness was low initially and continued to decline (-0.23 discrepant-points/yr), reaching anosognosia 3.2 years before dementia onset. INTERPRETATION: Aβ burden is associated with a progressive decrease in self-awareness of memory deficits, reaching anosognosia approximately 3 years before dementia diagnosis. ANN NEUROL 2020;87:267-280.
Authors: Maria Fernanda B Sousa; Raquel L Santos; Marcela L Nogueira; Tatiana Belfort; Rachel D L Rosa; Bianca Torres; Pedro Simões; Daniel C Mograbi; Jerson Laks; Marcia C N Dourado Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand Journal: Neurology Date: 2002-03-12 Impact factor: 9.910
Authors: Patrizia Vannini; Rebecca Amariglio; Bernard Hanseeuw; Keith A Johnson; Donald G McLaren; Jasmeer Chhatwal; Alvaro Pascual-Leone; Dorene Rentz; Reisa A Sperling Journal: Neuropsychologia Date: 2017-04-03 Impact factor: 3.139
Authors: Patrick O Monahan; Malaz A Boustani; Catherine Alder; James E Galvin; Anthony J Perkins; Patrick Healey; Azita Chehresa; Polly Shepard; Corby Bubp; Amie Frame; Chris Callahan Journal: Clin Interv Aging Date: 2012-06-14 Impact factor: 4.458
Authors: Lei Yu; Gary Mottola; Robert S Wilson; Olivia Valdes; David A Bennett; Patricia A Boyle Journal: Neuropsychology Date: 2021-10-28 Impact factor: 3.295
Authors: Patrizia Vannini; Bernard J Hanseeuw; Jennifer R Gatchel; Sietske A M Sikkes; Diana Alzate; Yesica Zuluaga; Sonia Moreno; Luis Mendez; Ana Baena; Paula Ospina-Lopera; Victoria Tirado; Eliana Henao; Natalia Acosta-Baena; Margarita Giraldo; Francisco Lopera; Yakeel T Quiroz Journal: JAMA Netw Open Date: 2020-12-01